Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Form 8-K--Settlement with Deutsche Bank

The amount will be easily calcaulated when the next 10Q is released the diff between the book value and the amount received will be taken as a long term capital loss - Possibly again if the securities were valued above book since they may have already taken a hit on the impairment,

Share
New Message
Please login to post a reply